About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1330 record(s)
Req # A-2021-001787
Adverse Drug Reaction (ADR) for AGALSIDASE BETA. Report number: E2B_04595165.Organization: Health Canada
January 2024
Req # A-2022-000123
Adverse Drug Reaction (ADR) for ALFUZOSIN HYDROCHLORIDE. Report number: E2B_05007203.Organization: Health Canada
January 2024
Req # A-2023-000126
Adverse Drug Reactions (ADRs). Report numbers: E2B_00675714, E2B_02977829, E2B_03128456.Organization: Health Canada
January 2024
Req # A-2023-001017
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-107682-242, Deputy Ministerial Meeting with Helium Developers Association of Canada.Organization: Health Canada
January 2024
Req # A-2023-001167
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-109485-722, Deputy Ministerial Meeting with the President and Chief Executive Officer of The Ottawa Hospital.Organization: Health Canada
January 2024
Req # A-2023-000483
A list of every drug approved under Health Canada's Special Access Program (SAP) between January 1, 2018 and July 6, 2023.Organization: Health Canada
January 2024
Req # A-2023-000968
Information on the intended use of a device listed on Medical Device Active License Listing (MDALL). Requesting it for the following: Licence No.: 95942, Type: System, Device class: 2, Device first issue date 2015-10-15, Licence name: VIASURE,…Organization: Health Canada
January 2024
Req # 2023-03
Request to obtain the technical quote for professional inspection and structural analysis services of the Bickerdike quay wall.Organization: Montreal Port Authority
January 2024
Req # 2024-01
Request aiming to obtain: The letters patent of the APM; A framework (a policy) of the company regarding official languages; The organizational chart of the company demonstrating the positions and required linguistic profiles.Organization: Montreal Port Authority
January 2024
Req # A-2023-02041
Briefing note 2023 LABOUR 000123 "Results from the Survey of Employees under the Federal Jurisdiction and Planned Next Steps"Organization: Employment and Social Development Canada
December 2023